AbbVie
ABBV
#25
Rank
โ‚น48.325 T
Marketcap
โ‚น27,339
Share price
-0.69%
Change (1 day)
40.92%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): โ‚น1.205 Trillion

According to AbbVie's latest financial reports the company's current earnings are โ‚น66.01 Billion. In 2025 the company made an earning of โ‚น618.00 Billion, an increase over its 2024 earnings that were of โ‚น348.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น1.205 T95.13%
2025 โ‚น618.00 B77.53%
2024 โ‚น348.11 B-40.54%
2023 โ‚น585.50 B-53.62%
2022 โ‚น1.262 T3.76%
2021 โ‚น1.216 T282.25%
2020 โ‚น318.32 B-59.67%
2019 โ‚น789.34 B62.13%
2018 โ‚น486.85 B-32.74%
2017 โ‚น723.86 B-1.99%
2016 โ‚น738.57 B18.65%
2015 โ‚น622.50 B180.5%
2014 โ‚น221.92 B-55.57%
2013 โ‚น499.50 B-6.86%
2012 โ‚น536.31 B56.05%
2011 โ‚น343.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น652.76 B-45.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.257 T 171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.035 T-13.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น41.69 B-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น237.3 Billion-119.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.061 T-11.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.413 T 17.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น670.23 B-44.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น80.84 B-93.27%๐Ÿ‡บ๐Ÿ‡ธ USA